Shanghai Fosun Pharmaceut... (SFOSF)
1.95
-0.06 (-2.99%)
At close: Apr 24, 2025, 8:00 PM
Shanghai Fosun Pharmaceutical () Revenue
Shanghai Fosun Pharmaceutical () reported an annual revenue of $41.07B, reflecting a -0.8% growth. For the quarter ending December 31, 2024, Shanghai Fosun Pharmaceutical () generated $10.16B in revenue.
Revenue (ttm)
$41.07B
Revenue Growth
-0.8%
Price / Sales Ratio
0.85
Revenue / Employee
$1.01M
Employees
40,557
Market Cap
8.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 41.07B | -0.80% |
| Dec 31, 2023 | 41.4B | -5.81% |
| Dec 31, 2022 | 43.95B | +12.68% |
| Dec 31, 2021 | 39.01B | +28.70% |
| Dec 31, 2020 | 30.31B | n/a |